I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension
This study is designed to investigate whether sympathoinhibition with moxonidine could provide added metabolic benefit compared to the second line therapy in the current guidelines.
body mass index
moxonidine
ace inhibitor
amlodipine 5 mg
hypertension
- 0 views
- 19 Feb, 2024